A phase 1 study of enoblituzumab in combination with pembrolizumab in patients with advanced B7-H3-expressing cancers.
暂无分享,去创建一个
A. Tolcher | P. Moore | N. Rizvi | J. Wigginton | R. Cohen | C. Aggarwal | D. Loo | E. Bonvini | J. Vasselli | J. Baughman | Francine Z Chen | Soyoung Yun